Skip to main content
. 2019 Nov 18;20(22):5791. doi: 10.3390/ijms20225791

Figure 2.

Figure 2

OS from treatment initiation of patients with VEGF-A rs699947 A/A vs. C/C (52 vs. 18.1 months, p = 0.043).